XML 24 R14.htm IDEA: XBRL DOCUMENT v3.25.3
BUSINESS SEGMENT
9 Months Ended
Sep. 30, 2025
BUSINESS SEGMENT  
BUSINESS SEGMENT

8.    BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as safety medical syringes and other safety medical devices. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance.  The accounting policies of our single reportable segment are the same as those for the Company as a whole.

The following are summaries of the Company’s sales and long-lived assets by geography:

Three Months Ended

Three Months Ended

Nine Months Ended

Nine Months Ended

    

September 30, 2025

    

September 30, 2024

    

September 30, 2025

    

September 30, 2024

U.S. sales

$

9,187,576

$

9,628,608

$

25,109,563

$

21,283,346

North and South America sales (excluding U.S.)

 

549,798

 

569,970

 

2,848,734

 

1,390,883

Other international sales

 

348,349

 

148,279

 

868,332

 

1,301,355

Total sales

$

10,085,723

$

10,346,857

$

28,826,629

$

23,975,584

Long-lived assets by geography are as follows:

    

September 30, 2025

    

December 31, 2024

Long-lived assets

U.S.

$

78,498,705

$

83,373,876

International

3,737,180

3,974,642

Total

$

82,235,885

$

87,348,518